Clinical Trial Update: Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

View source ↗

Summary

Status update on a non-interventional study evaluating the safety and effectiveness of elranatamab in patients with relapsed and refractory multiple myeloma und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• And Refractory Multiple Myeloma

Drugs mentioned

• Elranatamab (elranatamab)

Snippet

Sponsor: Pfizer | Conditions: Relapsed and Refractory Multiple Myeloma (RRMM) | Status: ACTIVE_NOT_RECRUITING